2 completed, 2 recruiting, 1 active not recruiting, 1 unknown. 3 Phase 3, 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 1, Completed 1, Recruiting 1 |
| Not applicable | 1 | Unknown 1 |
| Phase 4 | 1 | Completed 1 |
Follow Castration: new trials by email Literature Review of Castration trials Research Report on Castration
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Spinal Anesthesia and Spermatic Cord Block for Bilateral Orchiectomy bilateral orchiectomy - Orchiectomy, Spermatic Cord Block | Not applicable | Unknown | Sanpasitthiprasong Hospital | 18 | 2024-06-01 | 2024-03-15 |
| The Prognosis of Lipid Reprogramming With Rosuvastatin, in Castrated Egyptian Prostate Cancer Patients Rosuvastatin 20mg, surgical castration - Prostate Cancer Metastatic | Phase 4 | Completed | National Cancer Institute, Egypt | 70 | 2019-01-15 | 2021-03-02 |
| Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer Abiraterone, Bicalutamide, Degarelix - Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma | Phase 3 | Recruiting | SWOG Cancer Research Network | 1273 | 2018-09-24 | 2026-10-08 |
| Gonadal Tissue Cryopreservation for Fertility Preservation in Children With a Disorder of Sex Development Gonadectomy - DSD, 46,XY, DSD, Ovotesticular | Recruiting | Erin Rowell | 250 | 2018-04-04 | 2026-09-03 | |
| Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer Enzalutamide, NSAA, LHRHA or Surgical Castration - Prostatic Neoplasms | Phase 3 | Active not recruiting | University of Sydney | 1125 | 2014-03-01 | 2025-02-06 |
| Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer Bicalutamide, Doxorubicin hydrochloride, Estramustine Phosphate Sodium - Prostate Cancer | Phase 3 | Completed | M.D. Anderson Cancer Center | 306 | 1996-08-01 | 2018-10-31 |
Prostatic Neoplasms (5) · 46, XY Sex Reversal 5 (1) · Disorder of Sex Development, 46,XY (1) · Disorders of Sex Development (1) · Hypoalphalipoproteinemias (1) · Ovotesticular Disorders of Sex Development (1) · Sex Chromosome Disorders of Sex Development (1)
Erin Rowell (1) · M.D. Anderson Cancer Center (1) · National Cancer Institute, Egypt (1) · SWOG Cancer Research Network (1) · Sanpasitthiprasong Hospital (1) · University of Sydney (1)
United States (4) · Australia (1) · Canada (1) · Chile (1) · Colombia (1) · Egypt (1) · Ireland (1) · Mexico (1) · New Zealand (1) · Switzerland (1) · Thailand (1) · United Kingdom (1)
Brian Chapin (1) · Christopher Sweeney (1) · Erin Rowell, MD (1) · Ian Davis (1) · Randall E. Millikan, MD, PhD (1) · Rawisara Hongkrisadakorn, MD (1) · Sahachart Atichosakun, MD (1) · Thararat Wanthawong, MD (1) · Wattanachai Ungjaroenwathana, MD (1)
PMID 19029421, PMID 29525541, PMID 31157964, PMID 34928708, PMID 36480560, PMID 36990608, PMID 39404227
P30CA016672 (1), U10CA180888 (1)